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Introduction

Results

The National Comprehensive
Cancer Network (NCCN) has
issued guidelines for patients
to be screened for distress
at the nadir of chemotherapy
regiments. The LVPG
hematology-oncology clinic
is working to adhere to this
recommendation by instituting
clinical visits to address distress.

A total of 28 patients were seen for both an initial and follow-up DT score assessment. These data points are
represented in a distribution graph (Image 2), which demonstrate a general decrease in the DT scores reported
by patients following our clinical intervention.
The statistical analysis of these pre- and post-intervention DT scores are shown using the paired T-Test analysis
and demonstrate a statistically significant reduction in distress (Table 2).
Therefore, our study supports our hypothesis that clinical intervention can reduce the subjective distress
experienced by patients undergoing chemotherapy.
Table 1: Demographic Data
Median Age

(35-86)

Mean Pre-Intervention DT Score
(Subjective, 0-10 scale)

4.4

Participants, n

28

Mean Post-Intervention DT Score

2.2

Male

10

Mean Decrease in DT Scores

2.2

Female

18

Standard Deviation of Decreases

2.2

Number of Participants, n

28

Paired T-Test Score

5.33

(range) Yr

Problem Statement
It is unverified whether our
clinical intervention will produce
a statistically significant decrease
in the distress experienced in our
chemotherapy patient population.

Methods
Our project is a single-armed
prospective study to examine
the effect of clinical intervention
on the subjective distress
experienced by our patients. A
distress clinical appointment
consists of a visit with our nurse
practitioner, with or without an
MS4 medical student. Areas of
distress in the patient’s life are
reviewed, with interventions and
recommendations distributed as
seen fit by the clinician.
Our project utilized the Distress
Thermometer (DT) tool published
by the NCCN, which allows the
patient to grade their level of
distress on a scale of 0 – 10
(Image 1). An initial DT score
is compared to a follow-up
DT score following our clinical
intervention.
Our project received human
subject research exemption from
the IRB panel at LVHN.

64

Table 2: Distress Thermometer (DT) Scores and
Paired T-Test Analysis

Types of Cancer (% patient population)
Lung

25.0%

Breast

21.4%

Pancreatic

17.9%

Lymphoma

14.3%

Colon

3.6%

Other

17.9%

1.2 * 10^ -5
(< 0.0001)

P-Value

Table 2: Paired T-test analysis of distress thermometer
(DT) scores before and after distress intervention. Results
show a statistically significant (p-value < 0.0001) decrease
in DT scores.

Table 1: Demographics of patients screened
for distress over the course of this project.
Distribution of DT Scores (n=28)

Figure 1: The distress thermometer, published by the NCCN,
was utilized at each patient’s clinical visit to address patient
distress and to generate objective date for analysis.

Figure 2: Distribution of distress thermometer (DT) scores
reported by patients before our clinical intervention (“PreIntervention”, shown in green) and following our clinical
intervention (“Post-Intervention”, shown in blue). A shift to the
left, representing lower DT scores, is seen in patients following
our intervention.

Conclusions and Future Implications
We present our project as an initial affirmation of our clinic’s ability to reduce the distress experienced by
patients at the nadir of chemotherapy. Aspects of SELECT curriculum covered by this project include the study
of health systems, emotional intelligence and patient-centered care. Further aims of the project will be threefold; (1) to continue to see patients and analyze pre- and post-intervention distress thermometer scores, (2)
to understand the sources of distress in our patients’ lives by analyzing pre- and post-intervention patient
surveys that have been included at each patient visit (and have remained sealed thus far), and (3) to formalize
recommendations regarding distress screening to the general community of oncologists.
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